Semi-annual Report for 2026
Filed with SSE · · 210 pages · Chinese
Earlier from BeOne Medicines
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Voluntary Disclosure of Adjustment of Operating Performance Forecast for 2026
- Announcement on Voluntary Disclosure of Holding Conference Call for Company Performance
- Grant of Restricted Share Units
- Voluntary Announcement on Progress of Clinical Trial of BRUKINSA (Zanubrutinib Capsules)
Later from BeOne Medicines
- (688235)"BEONE MEDICINES LTD."Announcement on Voluntary Disclosure of Holding the Earnings Conference Call
- (688235)"BEONE MEDICINES LTD."Announcement on Convening the Q3 2026 Performance Briefing
Follow BeOne Medicines into a list and get an email when it puts out news.
Follow BeOne Medicines